Amendment No. 4 to Schedule 13D for Amneal Pharmaceuticals, Inc.

This Amendment No. 4 to Schedule 13D, filed by Dipan Patel, updates the ownership details of Class A Common Stock of Amneal Pharmaceuticals, Inc. As of the filing date, Patel beneficially owns 23,828,992 shares, representing 7.6% of the outstanding Class A Common Stock. The amendment also includes details of a Second Modification Agreement entered into by a trust controlled by Patel with Enterprise Bank & Trust, which involves the pledge of 3,050,000 shares of Class A Common Stock as collateral for a loan. The loan obligations mature on November 5, 2026. The filing provides additional information on the security agreements and control agreements related to the collateral.